Christopher Posner, President and CEO: Tvardi Therapeutics TVRD Sell · Filed 25/03/04

Trade details

Type: Insider sale
Amount: $2,769.25
Shares · price: 583 sh · $4.75 a share
Held after: 13,109 sh
Stock: Tvardi Therapeutics TVRD
Person: Christopher PosnerPresident and CEO
Trade date: 25/02/28
Filed: 25/03/04
Days to filing: 4 days

Sold 4.3% of holdings

Share of holding sold: 4.3%

Tvardi Therapeutics trades, last 26 weeks

What else happened in Tvardi Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/29~25/03/30

Christopher Posner's recent trades

Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$1,756
372 sh
$1,756
Filed 25/02/06
Traded 25/02/04
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$1,064
3,668 sh
$1,064
Filed 24/11/06
Traded 24/11/04
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$1,452
4,149 sh
$1,452
Filed 24/08/02
Traded 24/08/01
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$2,952
3,936 sh
$2,952
Filed 24/05/06
Traded 24/05/02
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$5,192
5,834 sh
$5,192
Filed 24/03/04
Traded 24/02/29